pemigatinib
innovent biologics,spdr s&p biotech,incyte,ishares biotechnology
['pemazyre', 'pemigatinib', '$ibb', '$xbi', 'innovent']
update: innovent reveals positive overall survival results for pemazyre (pemigatinib) in chinese patients with advanced cholangiocarcinoma at aacr annual meeting 2023. more info: $xbi $ibb $xph $pph 
Latest BioPharma/Biotech News. Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  https://t.co/lvTtwarrGT